Moneycontrol PRO
dilip shanghvi
Jump to
71 Results Found
  • Dilip Shanghvi resigns as MD of SPARC May 26, 2021 08:32 AM IST

    Dilip Shanghvi resigns as MD of SPARC

    Shanghvi will, however, continue to be associated with the company's board in his capacity as a non-executive director and chairman, it added.

  • What ‘second wave’ means for investors in Indian pharma Apr 12, 2021 10:25 AM IST

    What ‘second wave’ means for investors in Indian pharma

    Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma

  • Aditya Medisales case | Sun Pharma founder Dilip Shanghvi ordered to pay Rs 62.35 lakh for settling whistle-blower charges Feb 11, 2021 05:35 PM IST

    Aditya Medisales case | Sun Pharma founder Dilip Shanghvi ordered to pay Rs 62.35 lakh for settling whistle-blower charges

    The whistle-blower alleged that Sun Pharma and its subsidiary, Sun Pharmaceutical Laboratories, had diverted funds through Aditya Medisales, its sole distributor in India.

  • Dilip Shanghvi hasn't given up on Suzlon yet, says he will keep the stake May 08, 2019 01:26 PM IST

    Dilip Shanghvi hasn't given up on Suzlon yet, says he will keep the stake

    In 2015, Shanghvi bought 23 percent stake in Suzlon for Rs 18 billion, helping the company to return to profitability after it became India’s largest convertible-bond defaulter in 2012.

  • Opinion | Sun Pharma: New governance structure needed to protect investors' interest Jan 01, 2019 01:57 PM IST

    Opinion | Sun Pharma: New governance structure needed to protect investors' interest

    The whistleblower allegations have raised governance concerns at Sun Pharma. Investors are better placed in proactively raising their concerns with the board, to ensure that the new governance structure at Sun Pharma is robust, in their compliance and intent

  • Aditya Birla Group gets RBI licence to start payments bank Apr 04, 2017 06:49 PM IST

    Aditya Birla Group gets RBI licence to start payments bank

    The Aditya Birla Group today said it has received licence from the Reserve Bank of India to start payments bank.

  • Note ban hits billionaire club; Mukesh Ambani richest Indian Mar 07, 2017 07:18 PM IST

    Note ban hits billionaire club; Mukesh Ambani richest Indian

    India's richie rich club has shrunk by 11 people since the demonetisation last November, while Mukesh Ambani remains the richest Indian with a net worth of USD 26 billion, a study showed today.

  • Need to keep pace with industry on tech upgradation: Sun Pharma Feb 27, 2017 10:02 PM IST

    Need to keep pace with industry on tech upgradation: Sun Pharma

    The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that efforts are underway to meet global quality standards in both products and processes.

  • Sun Pharma Q3 profit dragged by slowdown in US & India sales Feb 14, 2017 03:25 PM IST

    Sun Pharma Q3 profit dragged by slowdown in US & India sales

    US generics business that accounts for nearly half of Sun Pharma sales grew at a moderate pace of 4 percent USD 507 million in the third quarter.

  • India Post Payments Bank starts pilot services Jan 30, 2017 08:58 PM IST

    India Post Payments Bank starts pilot services

    India Post Payments Bank (IPPB) today kicked off its operations by rolling out pilot services in Raipur and Ranchi.

  • India Post gets payments bank licence to start services Jan 28, 2017 04:04 PM IST

    India Post gets payments bank licence to start services

    "India Post has received payments bank licence. The service will be launched as per schedule," a Department of Posts official said.

  • Richest 1% own 58% of total wealth in India: Oxfam Jan 16, 2017 12:08 PM IST

    Richest 1% own 58% of total wealth in India: Oxfam

    The study, released by rights group Oxfam ahead of the World Economic Forum (WEF) annual meeting here attended by rich and powerful from across the world, showed that just 57 billionaires in India now have same wealth (USD 216 billion) as that of the bottom 70 percent population of the country.

  • ITI Re awaits clarity on domestic reinsurer status Jan 07, 2017 03:40 PM IST

    ITI Re awaits clarity on domestic reinsurer status

    Till now, GIC Re was the only Indian reinsurance company. It is entitled to the right of first refusal and also has the privilege of cessions which means a portion of risk is to be mandatorily ceded to it by an insurer.

  • Paytm gets RBI approval for payments bank Jan 03, 2017 08:02 PM IST

    Paytm gets RBI approval for payments bank

    Paytm today said it has received final approval of the Reserve Bank to formally launch its payments bank and it expects to start operations next month.

  • COMMENT: Is Sun Pharma suffering on account of unrelated diversification? Dec 21, 2016 06:24 PM IST

    COMMENT: Is Sun Pharma suffering on account of unrelated diversification?

    For investors, the Sun Pharma stock has long stood for a focus on growth, both through organic and inorganic routes. Is this lack of focus through unrelated investments the reason for its underperformance?

  • Dilip Shanghvi, Subhash Chandra want a slice of oil block action Nov 23, 2016 10:16 AM IST

    Dilip Shanghvi, Subhash Chandra want a slice of oil block action

    India‘s top pharma and media barons are lining up to have a fill of the country‘s oil blocks. Sun Pharma founder Dilip Shanghvi and media tycoon Subash Chandra are in the fray for the government‘s oil and gas blocks auction.

  • Sun Pharma to increase investments in MP, set up R&D facility Oct 22, 2016 05:58 PM IST

    Sun Pharma to increase investments in MP, set up R&D facility

    Sun Pharma has significant investment plans for its facility in Madhya Pradesh, the firm's Managing Director Dilip Shanghvi said on Saturday.

  • Mukesh Ambani's wealth at $22.7 bn equals Estonia's GDP: Forbes Oct 20, 2016 04:10 PM IST

    Mukesh Ambani's wealth at $22.7 bn equals Estonia's GDP: Forbes

    Similarly, Wipro's Azim Premji, the 4th richest Indian on the Forbes list, has a networth of USD 15 billion -- more than Mozambique's GDP of USD 14.7 billion.

  • Mukesh Ambani tops Forbes' 100 Richest Indians list Sep 22, 2016 07:51 AM IST

    Mukesh Ambani tops Forbes' 100 Richest Indians list

    Forbes India has released the annual India rich list and Reliance Industries' Chairman Mukesh Ambani has topped the Forbes' '100 Richest Indians' list with a net worth of USD 22.7 billion.

  • Time to do more to retain ownership of US market: Dilip Shanghvi Jun 08, 2016 10:09 PM IST

    Time to do more to retain ownership of US market: Dilip Shanghvi

    Over the last year, regulatory hassles have made US market tougher to navigate for Indian companies. Sun Pharmaceutical MD Dilip Shanghvi, however, says this is the time to dig in, and do more to maintain ownership of that market.

  • American R&D plus Indian entrepreneurship growth drivers:PepsiCo Jun 08, 2016 08:24 AM IST

    American R&D plus Indian entrepreneurship growth drivers:PepsiCo

    The bipartisan support for India from Democratic and Republican Senators was fantastic, said Pepsico-India Holdings Chairman and CEO D Shivakumar, adding, America's innovativeness, start-up and R&D combined with India's entrepreneurship on both product and services has a huge potential for both the countries.

  • Not perturbed over withdrawal of Payments Bank licences: Rajan Jun 07, 2016 02:14 PM IST

    Not perturbed over withdrawal of Payments Bank licences: Rajan

    RBI Governor Raghuram Rajan said he is not "overly perturbed" by surrender of Payments Bank licences by some companies but indicated that there could be a mechanism to ensure that entities apply for licences after due diligence as there is a cost involved in vetting them

  • Continue to remain opportunistic for acquisitions: Sun Pharma Jun 07, 2016 08:46 AM IST

    Continue to remain opportunistic for acquisitions: Sun Pharma

    The merger between Sun and Ranbaxy achieved closure towards the end of March 2015.

  • Sun Pharma falls 6% on weak sales guidance, price pressure woes May 31, 2016 01:25 PM IST

    Sun Pharma falls 6% on weak sales guidance, price pressure woes

    The company also said that the pharma major will continue to build speciality business which could impact short term profitability. It also cautioned that it could lose anywhere between 5-10 percent due to pricing pressure and peer consolidation in the US.

  • Payment bank score card: 3 down, 8 yet to open accounts May 25, 2016 02:09 PM IST

    Payment bank score card: 3 down, 8 yet to open accounts

    Back in August 2015, when the Reserve Bank of India handed out payments bank licences to 11 candidates, little did it know that three will be pulling out within a year. The payments bank model, which the RBI envisaged as a way to reach out to the unbanked, may be looking less profitable as a venture.

Sections
ISO 27001 - BSI Assurance Mark